The General Office of the Zhejiang Provincial People's Government issued a notice on “Certain Measures to Promote Industry-University-Research Linkage of Brain-Computer Interfaces”. Among them, it is mentioned that clinical research is supported. Combining clinical resource advantages, standardized management capabilities, etc., brain-computer interface clinical trial bases, clinical and translational wards, and clinical preparation queues are classified and built. Beds used only for clinical research are not included in the assessment and evaluation system for hospital bed efficiency, turnover rate, usage rate, and clinical performance related to disease diagnosis. Promote review and approval reforms. Implement special class guidance for brain-computer interface products that have entered the national special review process for innovative medical devices. Establish a brain-computer interface medical device product research and development list, and carry out “early intervention, research and review linkage” services to speed up the product launch process. Support Class II medical devices with clear clinical value and highly innovative brain-computer interfaces to enter the special review process, and the review time limit is reduced to less than 40 working days. Set up a green channel for priority testing of brain-computer-interface medical devices that are urgently needed clinically, and “immediate and immediate” implementation is carried out in terms of registration tests, inspections, etc.

The General Office of the Zhejiang Provincial People's Government issued a notice on “Certain Measures to Promote Industry-University-Research Linkage of Brain-Computer Interfaces”. Among them, it is mentioned that clinical research is supported. Combining clinical resource advantages, standardized management capabilities, etc., brain-computer interface clinical trial bases, clinical and translational wards, and clinical preparation queues are classified and built. Beds used only for clinical research are not included in the assessment and evaluation system for hospital bed efficiency, turnover rate, usage rate, and clinical performance related to disease diagnosis. Promote review and approval reforms. Implement special class guidance for brain-computer interface products that have entered the national special review process for innovative medical devices. Establish a brain-computer interface medical device product research and development list, and carry out “early intervention, research and review linkage” services to speed up the product launch process. Support Class II medical devices with clear clinical value and highly innovative brain-computer interfaces to enter the special review process, and the review time limit is reduced to less than 40 working days. Set up a green channel for priority testing of brain-computer-interface medical devices that are urgently needed clinically, and “immediate and immediate” implementation is carried out in terms of registration tests, inspections, etc.